128 related articles for article (PubMed ID: 21868542)
41. Acute Respiratory Tract Infection and 25-Hydroxyvitamin D Concentration: A Systematic Review and Meta-Analysis.
Pham H; Rahman A; Majidi A; Waterhouse M; Neale RE
Int J Environ Res Public Health; 2019 Aug; 16(17):. PubMed ID: 31438516
[TBL] [Abstract][Full Text] [Related]
42. Vitamin D levels and breast cancer characteristics: Findings in patients from Saudi Arabia.
Abulkhair O; Saadeddin A; Makram O; Gasmelseed A; Pasha T; Shehata H; Fakhoury HM
J Steroid Biochem Mol Biol; 2016 Nov; 164():106-109. PubMed ID: 26554935
[TBL] [Abstract][Full Text] [Related]
43. Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study.
Agborsangaya CB; Surcel HM; Toriola AT; Pukkala E; Parkkila S; Tuohimaa P; Lukanova A; Lehtinen M
Eur J Cancer; 2010 Feb; 46(3):467-70. PubMed ID: 20022237
[TBL] [Abstract][Full Text] [Related]
44. Vitamin D exposure and Risk of Breast Cancer: a meta-analysis.
Estébanez N; Gómez-Acebo I; Palazuelos C; Llorca J; Dierssen-Sotos T
Sci Rep; 2018 Jun; 8(1):9039. PubMed ID: 29899554
[TBL] [Abstract][Full Text] [Related]
45. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis.
Burgaz A; Orsini N; Larsson SC; Wolk A
J Hypertens; 2011 Apr; 29(4):636-45. PubMed ID: 21191311
[TBL] [Abstract][Full Text] [Related]
46. Serum 25-hydroxyvitamin D levels and prognosis in hematological malignancies: a systematic review and meta-analysis.
Wang W; Li G; He X; Gao J; Wang R; Wang Y; Zhao W
Cell Physiol Biochem; 2015; 35(5):1999-2005. PubMed ID: 25871640
[TBL] [Abstract][Full Text] [Related]
47. Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk.
Janowsky EC; Lester GE; Weinberg CR; Millikan RC; Schildkraut JM; Garrett PA; Hulka BS
Public Health Nutr; 1999 Sep; 2(3):283-91. PubMed ID: 10512563
[TBL] [Abstract][Full Text] [Related]
48. Circulating 25-hydroxyvitamin D concentration in German cancer patients.
Reinhold U; Schmitz B; Kurbacher C; Nagel W; Schmidt M; Malaisse WJ
Oncol Rep; 2008 Dec; 20(6):1539-43. PubMed ID: 19020739
[TBL] [Abstract][Full Text] [Related]
49. Impact of serum vitamin D level on risk of bladder cancer: a systemic review and meta-analysis.
Liao Y; Huang JL; Qiu MX; Ma ZW
Tumour Biol; 2015 Mar; 36(3):1567-72. PubMed ID: 25359617
[TBL] [Abstract][Full Text] [Related]
50. Re: Prospective study of vitamin D and cancer mortality in the United States.
Grant WB
J Natl Cancer Inst; 2008 Jun; 100(11):826. PubMed ID: 18505972
[No Abstract] [Full Text] [Related]
51. Prediagnostic serum vitamin D and breast cancer.
Hiatt RA; Krieger N; Lobaugh B; Drezner MK; Vogelman JH; Orentreich N
J Natl Cancer Inst; 1998 Mar; 90(6):461-3. PubMed ID: 9521171
[No Abstract] [Full Text] [Related]
52. Re: "The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women".
Grant WB
Am J Epidemiol; 2012 Nov; 176(9):838. PubMed ID: 23045473
[No Abstract] [Full Text] [Related]
53. Blood 25-hydroxyvitamin D levels and overall mortality in patients with colorectal cancer: a dose-response meta-analysis.
Wang B; Jing Z; Li C; Xu S; Wang Y
Eur J Cancer; 2014 Aug; 50(12):2173-5. PubMed ID: 24878065
[No Abstract] [Full Text] [Related]
54. Optimizing vitamin D concentrations for breast cancer risk reduction.
Stearns V; Visvanathan K
Medicine (Baltimore); 2013 May; 92(3):132-134. PubMed ID: 23619237
[No Abstract] [Full Text] [Related]
55. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis.
Kim Y; Je Y
Br J Cancer; 2014 May; 110(11):2772-84. PubMed ID: 24714744
[TBL] [Abstract][Full Text] [Related]
56. Vitamin D and breast cancer.
Shao T; Klein P; Grossbard ML
Oncologist; 2012; 17(1):36-45. PubMed ID: 22234628
[TBL] [Abstract][Full Text] [Related]
57. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer.
Mohr SB; Gorham ED; Kim J; Hofflich H; Garland CF
Anticancer Res; 2014 Mar; 34(3):1163-6. PubMed ID: 24596354
[TBL] [Abstract][Full Text] [Related]
58. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies.
Wang D; Vélez de-la-Paz OI; Zhai JX; Liu DW
Tumour Biol; 2013 Dec; 34(6):3509-17. PubMed ID: 23807676
[TBL] [Abstract][Full Text] [Related]
59. Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials.
Sperati F; Vici P; Maugeri-Saccà M; Stranges S; Santesso N; Mariani L; Giordano A; Sergi D; Pizzuti L; Di Lauro L; Montella M; Crispo A; Mottolese M; Barba M
PLoS One; 2013; 8(7):e69269. PubMed ID: 23894438
[TBL] [Abstract][Full Text] [Related]
60. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
